Skip to content

Dr. Verbeeck Iris

Active Private limited companyfounded 2021active for 5 yearsSmisstraat 46, 9100 Sint-NiklaasKBO/BCE: BE 0775.673.861

Lifetime

4 annual accounts with figures on one time axis
peak of €105,082 in 2024
€65,581▼ 37.6%
peak of €81,557 in 2024
€35,241▼ 56.8%
peak of €192,513 in 2024
€39,241▼ 79.6%
€422,240▲ 12×
Board1 name since 2021
1 director
Documentsfilings and deeds
01-04-2026121 days before the deadline
2025micro format
Gross margin from €105,082 to €65,581Result from €81,557 to €35,241Registered office moved from Waasmunster to Sint-Niklaas 01-04Dividend €188,513Equity from €192,513 to €39,241Debts from €36,525 to €422,240

Key points

from the 2025 annual accounts

Equity

€39,241 from €192,513 in 2024

Equity fell by 80% in 1 year.

Turnover

≈ €150,000 estimated

The micro format states no turnover.

Debts

€422,240 91% of the balance sheet
Financial debts 53%Suppliers 0%Taxes and wages 5%Other 42%

Of this, €198,708 falls due within a year.

Investments

€313,305 23.2 times depreciation
20222025

Green is investment, beige is depreciation.

Liquidity

0.81 was 6.23 in 2024

Short-term debts rose from €36,525 to €198,708.

Position in the sector

8.5%

Lower solvency than 87% of companies in human health. Sector median 63.0% · 21,337 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 875 companies had the same profile as Dr. Verbeeck Iris has now. Each dot stands for 3 companies, two years later.

96.6%
were still trading
1.9%
stopped another way
1.4%
went bankrupt
  • Small
  • 5 to 10 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 875 companies, not a prediction for Dr. Verbeeck Iris. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 13-10-2021
  • 100 sharesdeed of 15-10-2021
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0775673861
Registered office moved from Waasmunster to Sint-Niklaas The registered office moved from De Sombe 4, 9250 Waasmunster to Smisstraat 46, 9100 Sint-Niklaas · Board meeting of 11-02-2025 · Gazette deed
Incorporation Founding capital of €5,000, 100 shares · Founded by (comparante oprichter) · Founder: (comparante oprichter) · published on 15-10-2021 · Gazette deed
First establishment At the time the registered office was still in Waasmunster.
All 12 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Verbeeck Iris Sint-Niklaas €461,481 €65,581 8.5% -
HUISARTSENPRAKTIJK KALLOBAAN Beveren-Kruibeke-Zwijndrecht €489,787 €59,031 5.5% -
Dr. Vandewalle Hanneke Oudenaarde €481,073 €77,297 20.7% -
Dr. Vandendorpe Ann-Sophie - Huisarts Erpe-Mere €418,770 €68,705 9.4% -
Dr. Annaïk Van Branteghem, huisarts Ghent €381,205 €75,787 1.3% -
Sara Bobelyn - Huisarts Aalter €356,817 €78,897 76.6% -
ArteriaCarotis Zonhoven €450,548 €72,691 12.1% -

These companies have the same main activity as Dr. Verbeeck Iris: general medical practice (NACE 86210). They are comparable in size and age: total assets between €357,000 and €490,000, founded between 2020 and 2022.

Official details

Source: KBO
Status
Active since 13-10-2021Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.323.051.9119100 Sint-Niklaas, registered on 13-10-2021
Financial year end
31 December
Peppol
Reachable since 29-12-2025
Company details

Annual accounts 2025

€461,481▲ 101%
Filing
Filed on 01-04-2026, 121 days before the end of the filing period
Financials

Insights on Dr. Verbeeck Iris

Dr. Verbeeck Iris files the micro format. That format states no turnover. The gross margin fell from €89,747 in 2022 to €65,581 in 2025.

The balance sheet grew most from 2023 to 2025 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Verbeeck Iris

What is the company number of Dr. Verbeeck Iris?
The company number of Dr. Verbeeck Iris is 0775.673.861. The VAT number is the same number with BE in front: BE 0775.673.861.
Where is Dr. Verbeeck Iris based?
The registered office is at Smisstraat 46, 9100 Sint-Niklaas.Company details
What does Dr. Verbeeck Iris do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Verbeeck Iris?
Dr. Verbeeck Iris is a private limited company (BV).
When was Dr. Verbeeck Iris founded?
Dr. Verbeeck Iris was founded on 13-10-2021.
Is Dr. Verbeeck Iris still active?
Yes, Dr. Verbeeck Iris is an active enterprise in the KBO register.
What is the turnover of Dr. Verbeeck Iris?
The turnover in financial year 2025 is ≈ €150,000. This figure is estimated from the gross margin of €65,581 and 33 comparable companies (NACE 862). It probably lies between €110,000 and €180,000.Financials
Is Dr. Verbeeck Iris profitable?
In financial year 2025, Dr. Verbeeck Iris made a profit of €35,241.
Where can I find the annual accounts of Dr. Verbeeck Iris?
Dr. Verbeeck Iris filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Verbeeck Iris due?
Dr. Verbeeck Iris must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.